Editorials on STING for cancer immunotherapy

I recently published two Editorials on the use of STING agonists for cancer immunotherapy, you will find them here:

Berger, Lawler – 2018 – Novel non-nucleotidic STING agonists for cancer immunotherapy

Marloye, Lawler, Berger – 2019 – Current patent and clinical status of stimulator of interferon genes (STING) agonists for cancer immunotherapy